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Sulfurmustard(SM)isapotentvesicantthathasbeenemployedasachemicalweaponinvariousconﬂictsduringthe20thcentury.
More recently, mustard was used in the Iraq conﬂict against Iranian troops and civilians. At the present time there are more
than 40.000 people suﬀering from pulmonary lesions special bronchiolitis obliterans (BOs) due to mustard gas. SM increases the
endogenousproductionofreactiveoxygenspecies(ROS).NeutrophilGelatinase-associatedLipocalin2(Lcn2,NGAL)isamember
of the lipocalin superfamily for which a variety of functions such as cellular protection against oxidative stress have been reported.
Ten normal and Twenty SM-induced COPD patient individuals were studied. Assessment of NGAL expressions in healthy and
the patients endobrinchial biopsies were performed by semiquantitative RT-PCR, real-time RT-PCR, and Immunohistochemistry
analysis. While Normal control samples expressed same level of mRNA NGAL, expression level of mRNA-NGAL was upregulated
about 1.4- to 9.8-folds compared to normal samples. No signiﬁcant immunoreactivity was revealed in both samples. As we are
aware this is the ﬁrst report of induction of NGAL in patients exposed to SM. NGAL may play an important role in cellular
protection against oxidative stress toxicity induced by mustard gas in airway wall of patients.
1.Introduction
Sulfur mustard (SM) or bis (2-chloroethyl) sulﬁde, a rep-
resentative of chemical warfare agents (CWA), is a sturdy
alkylating agent with identiﬁed mutagenic and supposed
carcinogenic characteristics [1]. More recently, SM was used
by Iraqi forces to target Iranian army and civilians during
the latter years of the Iran-Iraq war lasting through 1984–
1988 [2]. From the public health point of view the delayed
toxicity and complication of SM is much more serious than
its acute poisoning, as experienced through the Iran-Iraq
conﬂict: About one-third of more than 1000,000 Iranians
w h ow e r ee x p o s e dt oS Ma r es t i l ls u ﬀering from long-term
respiratory, ocular, and dermal squeals, among which the
respiratory one is the most serious [3, 4].
Recently,bronchiolitis obliterans (BO)hasbeenreported
as a main respiratory clinical complication in patients
exposedtoSM[5,6]. Major symptoms of BO are represented
by progressive dyspnea and airﬂow limitations; moreover,
mucostasis and mucosal inﬂammatory reaction are usually
associated with BO [7]. A number of other factors have
been shown to be associated with development of BO such
as transplantations of bone marrow, lung, and heart-lung
[8], pulmonary infections [9], drug reaction [10], and toxic
inhalation [11]. However, some diﬀerences in the symptoms
of SM-related BO have been reported to be present from2 Journal of Biomedicine and Biotechnology
Table 1: Subject characteristics.
Groups N Sex
(M/F)
Age range Age mean ± SD P
Control group 10 9/1 39.0–44.0 41.3 ±2.5 .64
SM-injured group 20 20/0 36.0–58.0 43.2 ±6.4
those of BO caused by the other factors: no progressive
pattern along with ﬁbrosis. [12, 13].
Although the exact mechanisms of SM-associated respi-
ratory complications of delayed form are not fully under-
stood at present, it seems to be diﬀerent from mechanisms
responsibleforitsacutecomplications.Ithasbeenpostulated
that SM-induced pulmonary complications are a neutrophil
and/or lymphocyte disorder [14]. Moreover it has been
shown that the pathogenesis of BO is closely associated with
release of some inﬂammatory mediators from variety of cell
types including, epithelial cells, monocytes/macrophages,
neutrophils, eosinophils, and dendritic cells [15, 16]. This
condition is linked with increased production of reactive
oxygen and nitrogen species (ROS and RNS), resultsing
in oxidative stress that eventually plays an important
role in pathogenesis of various lung diseases such as
asthma and chronic obstructive pulmonary disease (COPD)
[17–19].
Lipocalin superfamily is a broad and evolutionary con-
served family of tiny extracellular proteins with a small
molecular mass and a β-sheet [20]. Neutrophil gelatinase-
associated lipocalin (NGAL) which is ﬁrst identiﬁed by
Kjeldsen is also termed as lipocalin-2 (lcn2) or human
neutrophil lipocalin (HNL) is a 25-kDa glycoprotein that
was at ﬁrst puriﬁed from granules of neutrophils [21].
Although the exact pathophysilogical roles of NGAL are not
currently fully understood, several possible functions have
been ascribed to NGAL, such as transportation of iron and
fatty acids [22, 23], induction of apoptosis [24], suppression
of bacterial growth [25], and modulation of inﬂammatory
responses[26].InadditionupregulationofNGALexpression
under oxidative stress condition has recently been demon-
strated and it has proposed a new function for NGAL
such as a protective factor against free radicals produced by
H2O2,oxidant compounds [27, 28].
In light of similarities between SM-induced pulmonary
complications of delayed form and a number of pulmonary
disorders whose pathogenesis oxidative stress and free
radicals are involved in, based on the assumption that
the expression of NGAL should be altered in SM-exposed
victims, the present study was designed to evaluate the
expression of NGAL at levels of mRNA and protein in airway
biopsy samples of SM-exposed patients in comparison with
unexposed group.
2.MaterialsandMethods
2.1. Study Design. Twenty patients (Table 1) who had suf-
fered from delayed respiratory complications due to the
exposure to SM through the 1988–1995 Iran-Iraq conﬂict
were grouped as the SM-injured one. The SM-exposure was
conﬁrmed through documented evidence of chemical expo-
suresbythemilitaryhealthservicesatthetimeofcontactand
beginning of respiratory symptoms instantaneously after the
exposure without symptom-free periods. Moreover, all the
patients exhibited symptoms of BO which were conﬁrmed
by high-resolution computerized tomography (HRCT) scan
data characterized by expiratory air trapping of more than
25% and mosaic parenchymal attenuation, and biopsy sam-
ples taken in previous studies. On the other hand, ten SM-
unexposed individuals were enrolled as a control group, who
were conﬁrmed as normal by chest X-ray ﬁlms and high-
resolution computerized tomography (HRCT) scan as well
as regular pulmonary function tests. All participants signed
an informed written-consent. This survey was conducted
in accordance with a protocol approved by Baqiyatallah
Medical Sciences University (BMSU) ethics committee. A
summary of the two subject characteristics is shown in
Table 1.
In this study, patients with other chronic pulmonary
diseases (such as asthma), lung cancer, autoimmune diseases
(such as rheumatoid arthritis), diabetes mellitus, pneumo-
nia, or acute infective bronchitis were excluded from the
examination target. In addition smokers, addicts, elders,
organ transplant recipients, or patients with occupational
history of toxic fume exposure were also excluded.
2.2. Endobronchial Biopsy Sampling. All participants under-
went the bronchoscopic examination via a ﬂexible ﬁber-
optic bronchoscope (Olympus BF1T, Tokyo, Japan). Endo-
bronchial biopsy samples were taken by a bronchoscopic
forceps (Olympus, Tokyo, Japan) through the bronchoscope.
2% lidocaine was used to anesthetize the upper respiratory
tract. Before beginning the procedure, 0.75mg atropine was
given to each case intramuscularly. Supplemental oxygen
was given during the procedure, and the oxygen saturation
was monitored continuously by the pulse oxymeter. Biopsy
samples were obtained from segmental and subsegmental
carinae of the right or left lower lobe and they were
immediately immersed in Tripure Isolation Reagent (Roche
applied science, Germany) at 4◦C and maintained at −80
◦C
till RNA extraction.
2.3. cDNA Synthesis. Total RNAs from biopsy samples
were isolated by Tripure Isolation Reagent (Roche Applied
Science, Germany) according to the manufacturer’s recom-
mendation. The extracted total RNAs were suspended in
20μl RNase-free water and stored at −80
◦Cf o rs u b s e q u e n t
procedures. The quantity and quality of puriﬁed RNAs
were veriﬁed by Nanodrop spectrophotometer (ND-1000,
Wilmington, DE) and electrophoresis in 1% agarose gel
(Cinnagene, Tehran, Iran), respectively. The puriﬁed total
RNAs were used as templates for cDNA synthesis. Reverse
transcription was carried out by SuperScript III reverse
transcriptase (Invitrogen, Carlsbad, CA) with 500ng of
extracted RNAs, followed by DNaseI (Invitrogen, Carlsbad,
CA) treatment and heat inactivation, to eliminate any
contamination with chromosomal DNA.Journal of Biomedicine and Biotechnology 3
Table 2: Sequence and characteristics of PCR Primers.
Gene (Accession ID) Primer sequence (5  to 3 ) Annealing Tm Product length (bp)
Lcn2 (NM 005564) Forward TCACCTCCGTCCTGTTTAGG 59
◦C 242
Reverse CGAAGTCAGCTCCTTGGTTC
β-actin (NM 001101) Forward TTCTACAATGAGCTGCGTGTGG 59
◦C 119
Reverse GTGTTGAAGGTCTCAAACATGAT
2.4. Assessment of NGAL Gene Expression. Semiquantita-
tive PCR of NGAL gene was performed using recombi-
nant Taq DNA polymerase (Cinnagene, Tehran, Iran) in
a thermocycler (mastercycler eppendorf, Hamburg, Ger-
many). Speciﬁc primers were designed with aid of primer3
(Input 0.4.0) software (http://frodo.wi.mit.edu/) based on
sequences placed in the NCBI GenBank database (http://
www.ncbi.nlm.nih.gov/)andinputtedtotheBLASTdatabase
(NCBI GenBank) to ensure that they had complete homol-
ogy with our interested genes (Table 2). Subsequent to initial
denaturation at 94
◦C for 5 minutes, cDNA was subjected to
30 cycles of PCR consisting of denaturation at 94
◦Cf o r3 0
seconds, annealing at 59
◦C for 30 seconds, and extension
at 72
◦C for 60 seconds followed by a 5-minute terminal
extension cycle at 72
◦C. PCR products were separated by
electrophoresis on a 2% agarose gel (Cinnagene, Tehran,
Iran), to determine successful ampliﬁcation.
Quantitative real-time PCR analysis was conducted in a
Rotor-Gene RG 3000 (Corbett Research, Sydney, Australia).
Ampliﬁcation was done using SYBR Green Premix (Takara,
Shiga, Japan) according to the manufacturer’s protocol. PCR
condition was as follows: initial denaturation at 94
◦Cf o r
1 minute pursued by 40 ampliﬁcation cycles consisting
of denaturation at 94
◦C for 20 seconds, annealing at
59
◦C temperature for 30 seconds and extension at 72
◦Cf o r
30 seconds. β-actin expression was used to normalize
threshold cycle (Ct) values and gave a control for relative
quantitative evaluation of the transcripts abundance.
2.5. Immunohistochemical Staining. For immunohistochem-
istry, details were already described elsewhere by us [29].
In summary, individual airway wall biopsies were ﬁxed with
4% buﬀered paraformaldehyde. The biopsies were extirpated
and immersed overnight in a phosphate buﬀer containing
30% sucrose. Sections, 20μm in thickness, were cut on a
cryostat and incubated with NGAL-antibody at appropriate
concentrations for 12 hours at 4◦C. The antibody employed
in this study included a rat monoclonal antibody raised
against NGAL of human origin (Santa cruz biothechnology,
Inc, USA) at a dilution 1:200. After incubation with the pri-
maryantibody, thesectionswereincubatedwithbiotinylated
antirat secondary antibody (Santa cruz biothechnology, Inc,
USA)forimmunostaining.Thesectionsforimmunostaining
were subsequently visualized using ABC complex (avidin-
biotinylatedperoxidasecomplex)system(VectorLaboratory,
Burlingame, CA, USA) with DAB as a substrate.
2.6. Statistical Analysis. Numerical data are expressed as
mean ± SD of fold changes of NGAL gene expression in
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Figure 1: Upregulation of Lcn2 in SM-injured patients. Gene
expressions (a) were measured by semiquantitative RT-PCR. Lcn2
was upregulated in SM-injured patients (Lanes 3–12). Only 10
samples have been shown, compared to two normal samples (Lanes
1 and 2). M: 100-bp marker. (b) Ratio of NGAL/beta-actin has also
been shown by a histogram.
three independent experiments. Diﬀerences between the two
groups were compared using student’s t-test (P<. 05)
3. Results
In the present study 20 airway biopsy specimens from SM-
injured patients and 10 samples from unexposed control
people were collected (Table 1). Expression was detected in
either of the samples.
The expression of NGAL mRNA was studied in the
SM-exposed specimens. First, semiquantitative RT-PCR was
carried out. Since the control samples expressed the equal
level of NGAL, only two of them were used for comparison
with the SM-injured patients. As presented in Figure 1 in
all SM-poisoned cases (Lanes 3–12) NGAL was upregulated
(Lanes 1 and 2).
Then, NGAL expression quantitatively evaluated in
the SM-injured patients by real-time RT-PCR. Our result
showed that expression of NGAL in mRNA level increased
from 1.4- to 9.8-folds compared with the control samples
(Table 3).4 Journal of Biomedicine and Biotechnology
Table 3: Lcn2 expression fold changes in SM-exposed patients in
comparison with control group (∗Statistical signiﬁcance: P<. 05).
No Fold changes of gene expression
(Real-time PCR)
P Value
1 1.40 ±0.28 .045
∗
2 2.32 ±0.23 .015
∗
3 2.04 ±0.41 .016
∗
4 2.21 ±0.51 .01
∗
5 2.07 ±0.69 .04
∗
6 2.52 ±0.34 .03
∗
7 4.05 ±0.60 .007
∗
8 6.11 ±0.87 .005
∗
9 5.01 ±0.53 .004
∗
10 5.27 ±0.81 .001
∗
11 4.10 ±0.57 .007
∗
12 4.90 ±0.84 .005
∗
13 4.31 ±0.43 .004
∗
14 9.80 ±1.05 .001
∗
15 0.87 ±0.95 .3
16 2.45 ±0.26 .01
∗
17 1.71 ±1.13 .087
18 0.92 ±0.45 .06
19 6.15 ±0.98 .001
∗
20 7.92 ±0.75 .001
∗
To investigate whether SM induces NGAL expression
in protein level immunohistochemistry was performed. A
weak expression of NGAL was observed in the bronchial
epithelial cells of control group, suggesting basal expression
(Figure 2(a))Incontrast,inSM-injuredpatients,immunore-
actiovity for NGAL in the same cells was negative; in par-
ticular, the bronchial epithelial cells display immunonegative
reactivity for NGAL (Figure 2(b)).
4. Discussion
Iran is one of the countries in which SM-injured patients
are prevalent, and thousands of Iranians are still suﬀering
from long-term complications of such chemical warfare
agents [3]. The latest reports have shown that BO is the
main chronic pulmonary complication among Iranian SM-
exposed patients which poisoned with this inhalant during
Iran-Iraq conﬂict [13]. Unfortunately very little is identiﬁed
abouttheexactmolecularmechanismsinvolvedinstructural
modiﬁcations and pathophysilogical symptoms observed in
the lung of these patients.
Our results in the present study revealed that the expres-
sion of NGAL at mRNA levels was upregulated signiﬁcantly
in airways of SM-exposed patients in comparison with
unexposed control group.
To our knowledge, there have been no reports on the
expression change of NGAL and its interaction with SM-
induced pulmonary complications of delayed form.
BM
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Figure 2: Light micrograph of NGAL-immunoposive cells in the
bronchial epithelium. (a) NGAL-immunoreactivity in bronchial
epithelial cell of control group. NGAL-immunopositivity weakly
demonstrated in substantial number of cells vicinity to basement
membrane (BM) (short arrow) and rarely in the luminal border
of epithelial cell (long arrow). (b) Immunoreactivity intensity
decreased at bronchial epithelial cell of chemical injured patients
and no immunoreactions is seen throughout the section. Note
that the thickness of epithelial cell layer in experimental group is
higher than control group due to chemical injury. BMbasement
membrane.
There have recently been studies in which the upregula-
tion of its expression under oxidative stress conditions was
revealed and thus a new functional role of NGAL is proposed
as a protective factor against free radicals produced by
oxidant compounds such as H2O2 [27, 28]. NGAL has been
suggested to play roles in downregulating the inﬂammatory
response by binding to some cytokines and reducing their
biologic activities. NGAL has been reported to stimulate the
apoptosis, which may contribute to its anti-inﬂammatory
activity [30]. The overexpression of NGAL has been shown
to reduce the adhesion and invasion of cancer cells in vitro
and in vivo [31, 32].
The recent ﬁnding that SM increases the endogenous
production of reactive oxygen species (ROSs) [33]h a s
suggested that ROSs are likely to be involved in the toxicity
of this chemical warfare agent-induced toxicity [34, 35].
The imbalance between oxidant and antioxidant is suggested
to be involved in the pathophysiology of SM-induced
pulmonary lesions, and thus the antioxidant treatment may
be useful in the patients [6]. Several studies have shown the
importance of oxidative stress in the pathogenesis of chronic
obstructivepulmonarydisease(COPD)[36–38],whosesigns
and symptoms are similar to delayed pulmonary sequels
observed in SM-injured patients.
Similar to our ﬁndings, Keatings and Barnes [39]
reported that the concentration of human neutrophil
lipocalin (HNL/NGAL) was elevated in the sputum of
patients with asthma or chronic obstructive pulmonary dis-
ease (COPD) and could be a better discriminating indicator
in comparison with myeloperoxidase (MPO). In anotherJournal of Biomedicine and Biotechnology 5
study, Eichler et al. [40] showed that the serum levels of
HNL/NGAL in patients with cystic ﬁbrosis were noticeably
increased and strongly postulated that the determination of
serum concentration of this protein may be another useful
diagnostic tool for monitoring of neutrophilic inﬂammation
in CF patients.
In addition, it has been demonstrated that the level of
HNL/NGAL was signiﬁcantly increased in bronchoalveolar
lavageﬂuid(BAL)fromsubjectswithsubclinicalemphysema
conﬁrmed by computerized tomography compared with
relativelyheavysmoker-personswithoutemphysema[41].In
thiscaseitisacceptedthatpulmonaryemphysemarepresents
a result of proteinase–antiproteinase imbalance in the lungs,
which can be induced by cigarette smoke [42]. That leads
to the release of large amounts of toxic oxygen radicals
and a variety of granule proteins from neutrophils, among
which NGAL is included as the most important one [43].
But, our histological ﬁndings did not display emphysema
in the lung of SM-exposed patients, indicating that SM-
exposure did not activate the proteinase-antiproteinase
imbalance.
In contrast to the mRNA level, the present study showed
the localization of NGAL in bronchial epithelial cells in SM-
exposed and unexposed patients; no signiﬁcant expression
level of NGAL protein was detected in both groups.
The unchanged expression of NGAL protein after
long-term SM induction was however not parallel by
increased mRNA expression. Exhibited paradoxical discrep-
ancy between the mRNA levels and protein levels of NGAL is
mostlikelyduetotranslationaleﬃciencyorposttranslational
regulation. Therefore lack of NGAL protein is one important
reason of remaining and progressive lesion. NGAL is a
protective factor against free radicals, probably able to
decrease the toxic eﬀects of free radicals and improve clinical
conditions.
We have previously observed that a 4-month adminis-
tration of N-acetylcysteine in patients exposed to SM could
signiﬁcantly improve FEV1/FVC over placebo [14, 44].
It seems that the upregulation of NGAL in these patients
may play an advantageous role in decreasing oxidative
stresses induced by ROS as a cytoprotective agent to reduce
thelunginjuryandimprovepatients’symptoms,butoptimal
cure has not been taken place.
In conclusion our study demonstrated that expression of
NGAL in mRNA levels in sulfur mustard injured veterans
signiﬁcantly increased compared with control group. The
upregulation could act as a cytoprotective factor to ame-
liorate sulfur mustard-induced toxicity. But following the
increasing folds in mRNA the NGAL protein expression due
to unknown reason does not increased and this is the main
reason for unconvalesce in this disease. However, further and
complementary studies are required to clarify mechanisms
underlying SM exerts cytotoxicity.
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